Recce Pharmaceuticals (ASX:RCE) Net Change in Cash : A$-2.07 Mil (TTM As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Recce Pharmaceuticals Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Recce Pharmaceuticals's Net Change in Cash for the six months ended in Dec. 2024 was A$-2.47 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was A$-2.07 Mil.

Recce Pharmaceuticals Net Change in Cash Historical Data

The historical data trend for Recce Pharmaceuticals's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recce Pharmaceuticals Net Change in Cash Chart

Recce Pharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Net Change in Cash

Get a 7-Day Free Trial

2.28

18.19

-9.29

-10.02

2.85

Recce Pharmaceuticals Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Change in Cash	Get a 7-Day Free Trial													-9.73	-0.29	2.45	0.41	-2.47

Recce Pharmaceuticals Net Change in Cash Calculation

Recce Pharmaceuticals's Net Change in Cash for the fiscal year that ended in Jun. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-13.009	+	-0.142	+	16.004	+	0
	=	2.85

Recce Pharmaceuticals's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -6.924 + -0.408 + 4.86 + 0

= -2.47

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-2.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recce Pharmaceuticals Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Recce Pharmaceuticals's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Recce Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Recce Pharmaceuticals Ltd (ASX:RCE) » Definitions » Net Change in Cash

Comparable Companies

ASX:EZZ ASX:ACW ASX:NUZ ASX:ALA ASX:ATH ASX:PIQ ASX:LTP ASX:TYP ASX:RAD ASX:ILA VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX

Traded in Other Exchanges

RECEF:USA R9Q:Germany

Address

180 George Street, Level 23, Salesforce Tower, Sydney, NSW, AUS, 2000

Website

https://www.recce.com.au

Recce Pharmaceuticals Ltd is an Australia-based globally-focused biotechnology company engaged in the development and commercialization of a new class of antibiotics. The company operates in only one business segment being research and development of pharmaceutical drugs. The firm operates in three geographic segments being Australia, the United Kingdom, and the United States of America, of which the majority of the revenue comes from Australia. The company offers antibiotic drugs to treat diseases caused by various bacteria namely Sepsis, Neisseria gonorrhoeaei, Escherichia coli, Mycobacterium abscessus, and others.

Recce Pharmaceuticals Headlines

No Headlines